$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What drug class does baricitinib belong to?
2026-02-01 22:25:32
Check Details
Is baricitinib a biologic?
2026-02-01 22:25:32
Check Details
Preliminary efficacy observation after 20 days of lorlatinib/lorlatinib treatment
2026-02-01 22:25:32
Check Details
Lorlatinib/lorlatinib: Analysis of the difference between 25mg and 100mg specifications
2026-02-01 22:25:32
Check Details
Can lorlatinib/lorlatinib be taken long-term?
2026-02-01 22:25:32
Check Details
How much does a box of lorlatinib/lorlatinib cost?
2026-02-01 22:25:32
Check Details
Are there generic versions of lorlatinib/lorlatinib?
2026-02-01 22:25:32
Check Details
The fastest resistance time to lorlatinib/lorlatinib
2026-02-01 22:25:32
Check Details
Lorlatinib/lorlatinib’s domestic launch time and its significance in the treatment of lung cancer
2026-02-01 22:25:32
Check Details
Discussion on the monthly treatment cost of lorlatinib/lorlatinib
2026-02-01 22:25:32
Check Details
Lorlatinib/Lorlatinib: Functional Analysis and Main Therapeutic Areas
2026-02-01 22:25:32
Check Details
Which patients is obeticholic acid suitable for? What should patients pay attention to when taking medication?
2026-02-01 22:25:32
Check Details
1
2
...
972
973
974
975
976
977
978
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
2
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
3
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
4
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
5
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
6
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
7
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
8
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
9
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
10
Elagolix Side Effects and Safety Guide
11
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
12
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation